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Abstract 
This paper aims to calculate the rates of Chlamydia infection at genitourinary 
medicine (GUM) clinics in England.  Data on the number of cases is available from 
KC60 returns from GUM clinics in the Northwest and Southwest of the country, but 
the population exposed to risk is required in order to calculate rates of infection.  
This study tests three different methods of deriving the exposed to risk: Thiessen 
polygons, 15 mile boundaries, and 30 minute drive-times.  It was found that the 
method of deriving the population exposed to risk did not significantly affect the 
Chlamydia rates.  Thus the best choice of method was deemed to be the simplest 
approach, the Thiessen polygons.  The 15 mile and 30 minute drive-time models 
did, however, highlight substantial differences in the accessibility of GUM services 
between the Southwest and the Northwest.   1. INTRODUCTION 
 
Chlamydia trachomatis is the most prevalent sexually transmitted disease (STD) in 
the Western world
1 and the most commonly diagnosed STD at genitourinary 
medicine (GUM) clinics in the UK
2.  In about 75% of infected women and 50% of 
infected men, it is asymptomatic
3 but the long-term effects of infection can be 
serious, including chronic pain, ectopic pregnancy and infertility, as well as being 
the most frequent cause of pelvic inflammatory disease
1.  Although uncomplicated 
Chlamydia infection can usually be cured with a single short course of antibiotics, 
individuals can be re-infected.   
 
It is estimated that Chlamydia trachomatis costs the NHS up to £100 million each 
year both in treating the infection and in addressing the long-term consequences.  
And according to the Health Protection Authority (HPA), Chlamydia diagnoses 
have been rising steadily since 1995
4.  However, these statistics are based on a 
count of the number of individuals infected with Chlamydia.  This approach is 
widely used because the data to calculate it are easily available.  GUM clinics 
submit returns to the HPA which provide data on the number of Chlamydia 
diagnoses they have made.   
 
However, technological developments have changed our ability to diagnose and 
report the presence of disease.  New initiatives, such as the National Chlamydia 
Screening Programme and the “Condom Essential Wear” campaign, are 
encouraging more people to get tested.  The rise in disease diagnoses may reflect these changes.   Without knowing the size of the population from which these 
individuals come, it can be difficult to compare meaningfully between groups or 
over time.   
 
The ideal measure of Chlamydia infection would be a rate – the number of infected 
individuals divided by the total population at risk of infection.  However, identifying 
the population at risk is not straightforward.  The current approach taken by the 
Health Protection Authority in their calculations is to aggregate the returns made 
by the GUM clinics in each Strategic Health Authority (SHA) and then to divide by 
the total population in that SHA
2.  However, this measure includes a number of 
individuals who are not at risk of Chlamydia, such as children.  It also includes 
individuals who would not have attended the clinic because it is too far away from 
their home.  Moreover, much of the detail of the differences between regions has 
been lost because the data for the clinics have been aggregated.   
 
This study will explore alternative methods of deriving the population exposed to 
risk of Chlamydia and will use this population to calculate rates for each clinic.  
There are a number of techniques using a Geographic Information System (GIS) 
which can help us to allocate populations to clinics and improve upon the rates 
that are currently provided by the HPA.   
 
With accurately calculated rates, we can begin to compare across locations in the 
UK.  In an era of limited resources, it is important to know which areas to target in 
order to ensure that measures to reduce disease incidence are implemented where they are most needed.  This may mean sending extra resources to places 
with high rates or alternatively, it may mean asking questions about why some 
areas have much lower rates than their neighbours.  Do these areas have 
genuinely lower rates and if so, why?  Or do they represent areas where GUM 
services are being under-utilised and where additional efforts are needed to 
encourage individuals to attend for testing?  It is only once we have reliable 
measures of Chlamydia infection that we can begin to think about tackling these 
questions.   
 
The objectives of this study are: 
•  To derive the population for whom each clinic is the nearest GUM service 
using Thiessen polygons 
•  To derive the population for whom each clinic is “accessible” – i.e. within 15 
miles 
•  To derive the population for who live within 30 minutes driving time of each 
clinic 
•  To compare these populations to explore whether GUM clinics suffer from 
accessibility problems which warrant the additional complexity of the drive-
time model 
•  To calculate prevalence rates of Chlamydia for each clinic in the Northwest 
and Southwest of England using as a denominator each of the populations 
described above.. 
•  To explore whether there are any spatial clusters of Chlamydia rates   2. DATA 
 
The data have been taken from KC60 returns made by GUM clinics in the 
Northwest and Southwest Strategic Health Authority Regions of England.   The 
KC60 return was conceived primarily as a way to measure the workload of GUM 
clinics but actually provides the main source of data on sexually transmitted 
diseases
5.  All GUM clinics have a statutory responsibility to provide information 
via the KC60 form on all clinic attendees each quarter.  The limited data reported 
include: 
• condition; 
• sex; 
•  number of male cases which were homosexually acquired; and 
• age  group.
6   
 
We will use the data reported in 2001, as they were provided for the majority of 
clinics in the Northwest and Southwest regions and, as this paper’s main aim is to 
look at the feasibility of different approaches to deriving rates, the actual timeframe 
of the data is not particularly relevant.  
 
The study will concentrate on the Northwest and Southwest regions because the 
decision to publish the information disaggregated by clinic is made at the local 
HPA level and we were able to obtain data only for the Northwest and Southwest 
regions.   
 The clinic data were cross-checked against the list of clinics in the HPA audit of 
GUM clinic waiting times
7 in order to ensure that no clinics were excluded from the 
study because of failure to provide permission for their KC60 data to be reported 
at the clinic level.  If any clinics are missed, the effect would be to underestimate 
the rates in the surrounding clinics.  To see this, imagine a region with 4,000 
people and two clinics, A and B.  These clinics have reported 200 and 250 cases 
respectively on their KC60 returns and there are 2,000 people in the catchment 
area of each clinic (see Figure 1) 
 
Figure 1.  Example catchment area with two clinics  
 
 
Now imagine that there is actually a third clinic, C, which was excluded from the 
original analysis.  Some of the people from both clinic A and clinic B actually 
should be in the catchment area of clinic C, as in Figure 2.  The result is that the 
catchment areas for clinics A and B get smaller, meaning that they have a smaller population than they did before we included clinic C but the same number of cases 
reported.  This would mean a smaller denominator when calculating the rate and 
hence a higher rate.  We have done our best to ensure that we have included all 
GUM clinics in the Northwest and Southwest in order to avoid this sort of 
underestimate.   
 
Figure 2.  Example catchment area for 3 clinics.  
 
 
We have been able to identify two clinics as part of this cross-checking process, 
Westmorland General Hospital and Furness General Hospital, which chose not to 
allow their numbers of diagnoses to be released in 2001.  We have still computed 
the exposed to risk for these clinics and thus ensured that the denominators for 
the clinics around them are not distorted in the way illustrated in the example 
above.  However, without knowing how many people have been diagnosed with 
Chlamydia, it has not been possible to compute rates for these clinics.    
The GUM clinic is not the only setting in which individuals can seek diagnoses and 
treatment for sexually transmitted diseases.  Family planning clinics and General 
Practitioners’ (GP) surgeries also offer these services.  For approximately 40% of 
individuals who eventually attend a GUM clinic, their GP will be their first point of 
contact
8.   
 
Because the KC60 data are clinic-specific, the outcome measure will be the rate of 
Chlamydia diagnosed at clinics rather than the rate of the disease in the general 
population.  To address this problem, we would have preferred to use a data 
source which included diagnoses in all healthcare settings but no such data 
source currently exists.  Some other sources that we considered were:  
 
•  The National Chlamydia Screening Programme (NCSP).  The NCSP was 
launched in England in 2003 and it is hoped that it will cover the whole of 
the country by the end of 2007
9.  It offers screening to 16-25 year olds in 
settings outside of the GUM clinics, such as local pharmacies.  However, 
whilst this age group represent the largest number of cases diagnosed each 
year
10, people aged over 25 are still regularly diagnosed with Chlamydia 
and should be included in both the count of individuals infected and the total 
population at risk of infection.   
 
Although the NSCP is likely to represent a significant source of data on 
Chlamydia diagnoses in the future, it currently does not cover the whole country and data are not available even for those areas which are covered.  
The data collected are detailed, including an individual’s postcode of 
residence, but it is unclear whether these data will be made available to 
researchers given concerns regarding confidentiality.   
 
•  The General Practice Research Database (GPRD).  The GPRD includes 
anonymised records for 3.4 million active patients
11.  It allows researchers 
to analyse sexually transmitted disease rates as diagnosed within general 
practice.  But policies vary by locality and many GPs’ surgeries will 
recommend that an individual goes to a GUM clinic for testing, confirmation 
of a result and/or treatment
12.  As a result, the actual diagnosis may be 
made and recorded outside of the general practice setting.  It is estimated 
that only 25% of women and 5.1% of men receive treatment from their 
GP
13.   
 
•  Microbiology laboratory reports.  All laboratories in England and Wales 
were invited to report on sexually transmitted diseases which they diagnose 
and the results were published quarterly in Communicable Disease Report 
(CDR) Weekly, now published as the Health Protection Report.  These 
reports provide data on all tests carried out.  This means that they cover all 
healthcare settings, however there can be double counting, such as when 
an individual is initially tested at a GP’s surgery but then referred to GUM 
clinic and retested to confirm the result.  Moreover, since reporting is 
voluntary, a number of laboratories do not report.
4    
It is believed that GUM clinic data captures the largest number of cases, since 
most cases are thought to present at a GUM clinic at some stage
14, and KC60 is 
certainly the most widely used in the ongoing discussion about trends in STD 
incidence in the UK.  For the purposes of this study we have therefore chosen to 
use these data in spite of their limitations.   
 3. METHODS 
 
3.1 DERIVING THE POPULATION EXPOSED TO RISK – THE THEORY 
 
In calculating rates, it is vital that we do not violate the principle of correspondence 
– i.e. we must ensure that events included in the numerator correspond with the 
exposed to risk in the denominator
15.  Our numerator includes all Chlamydia cases 
diagnosed at a particular GUM clinic.  Therefore our denominator should only 
include those people at risk of being included in the numerator.  This is not simply 
the total population in a given area.  Some people, for example very young 
children, have a virtually non-existent risk of contracting the disease.  Chlamydia is 
almost exclusively sexually transmitted so the population at risk should exclude 
those who are not sexually active.  Moreover, the denominator for each clinic 
should only include those individuals who, were they to suspect an STD, would 
attend that clinic.   
 
Taking the first consideration, we find that some simplifying assumptions are 
required.  There is no dataset available which provides a count of the total number 
of sexually active individuals in each region.  The National Survey of Sexual 
Attitudes and Lifestyles II (NATSAL II), a nationally representative survey of sexual 
behaviour in Britain, was interested primarily in the behavioural correlates of HIV 
transmission
16.  It defined the sexually active population was defined by an age 
interval.  Those under 16 and over 44 years old were considered to be at minimal 
risk of STD transmission and were therefore excluded from the study.  The National Chlamydia Screening Programme also sets the lower age band at 16.  In 
both cases this is likely to be because 16 is the age of consent, below which 
sexual activity is not legally permitted.   
 
It is well known that sexual activity does begin earlier.  A study by Stone and 
Ingham
17 found that the median age at which young people accessed sexual 
health services for any reason as 15 years.  But those under 16 represented 
approximately 2% of all Chlamydia cases in 2006 and those over 45 accounted for 
1%
18.  Choosing the age range 16-44 means that we will account for the vast 
majority of the population at risk, and by maintaining consistency with the NATSAL 
data we will be able to compare the rates that we derive with data on the 
prevalence of certain sexual behaviours derived from NATSAL II.   
 
Our numerator data are taken from GUM clinics.  To derive an appropriate 
denominator we still need to determine which individuals would attend which 
clinics.  One approach would be to assume that people attend the clinic in their 
Primary Care Trust (PCT) or to use some other similarly convenient administrative 
boundary.  However, a number of PCTs contain more than one clinic.  In these 
areas, data would have to be aggregated.  We would lose some of the detail that 
might tell us about differences between clinics that share an administrative area.  
For example, as shown in Figure 3, Newquay and District Hospital and Royal 
Cornwall Hospital at Treliske were both part of the Central Cornwall PCT.  
However, our calculations found that the lowest rates of Chlamydia were at the 
Newquay clinic whilst some of the highest were at the Royal Cornwall clinic.  Why two clinics located so close to one another should have such different rates is an 
interesting question which we would have missed had we simply aggregated their 
data because they were in the same PCT.   
 
Similarly, in PCTs without a GUM clinic, we would have to assume that people do 
not access any GUM services.  However this assumption is likely to be false.  A 
PCT is an arbitrary administrative border and there is no reason why people would 
not cross it to access nearby services.  For example, Teignbridge PCT has no 
GUM clinic.  However, Torbay Hospital lies very close to its border.  It might be 
reasonable to suppose that if people from Teignbridge suspect they have an STD, 
they travel to Torbay.   
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 3.  Southwest clinics and Primary Care Trusts 
A more realistic assumption might be that people attend the clinic located nearest 
to them.  When a sexually transmitted disease is suspected an individual can 
attend a GUM clinic directly, or may be referred by a GP.  Attending a clinic has a 
cost in terms of time and expense so it might be reasonable to assume that each patient chooses to attend their nearest clinic.  But “nearest” can mean a lot of 
different things.  It can refer to distance or to the time taken to travel there.  This 
paper will explore a variety of different ways of measuring a patient’s nearest 
clinic.   
 
The simplest way or measuring, or identifying, a patient’s nearest clinic is called a 
Thiessen (or Voronoi) polygon.  A Thiessen polygon demarcates an area around 
each clinic.  Within this area lie all the locations for which the Euclidean distance 
(i.e the distance “as the crow flies”) to this clinic is less than the Euclidean distance 
to any other clinic
19.   Thiessen polygons can be drawn by hand by connecting 
each clinic to all the surrounding clinics.  The lines connecting the clinics are then 
perpendicularly bisected.  The smallest area enclosed by joining the perpendicular 
bisectors is the Thiessen polygon.   If any place is equidistant from two clinics, it 
will lie on the boundary of the polygon.   If it is equidistant from three or more 
points, it will form one of the vertices of the polygon.  In practice, these polygons 
are more usually constructed using a computer program.   
 
A problem with the Thiessen polygons is that although they assign everyone to a 
clinic, there will be people who simply live too far away from a clinic for it to be 
practical for them to attend.  In this case, it is likely that they will seek treatment in 
an alternative setting, such as a GP surgery or family-planning clinic.  So these 
people should not be included in the denominator for their nearest GUM clinic 
because they are not at risk of attending any GUM clinic.   
 There is no established definition of “remoteness” from health services.  We have 
chosen to classify those who live more than 15 miles from a GUM clinic as being 
remote from this service.  This is based on the NHS policy of reimbursing travel 
costs to those who live more than this distance from the clinic
20.   
 
Both the Thiessen polygon and the boundary approaches are distance-based – 
“nearness” is defined based on the straight-line or “crow-fly” distance between the 
clinic and the individual’s address.  Crow-fly distances have a distinct advantage of 
being simple to measure.  However, they may not correspond very well to the 
routes that people take in the real world.  The nearest clinic might be only 2km 
away but if you have to cross a river and there is no bridge you may have to travel 
much further to reach the clinic than a crow-fly distance would predict.   
 
It is possible instead to base our model on the amount of time which it takes to 
travel from a given point to the nearest clinic.  Individuals who live in locations 
where the travel time to the nearest clinic is considered too long should be 
excluded from the denominator.  As with those for whom the journey is too far, it is 
likely that they would seek treatment in an alternative location.   
 
Much like “remoteness” there is no established duration that is considered “too 
long” to expect individuals to travel.  A number of studies of the accessibility of 
NHS services have used a drive time of more than 30 minutes
21,22,23 and this 
paper will follow that convention, though we will also examine the population 
distribution of drive times in 10 minute intervals.   3.2 DERIVING THE POPULATION EXPOSED TO RISK – METHODS 
 
The starting point for all the calculations was to geo-reference each clinic based 
on its postcode.  The clinic location would provide the starting point from which all 
other calculations of distance would be made.  Northing and Easting grid 
references were obtained for each clinic based on the postcode.  This was done 
using the 2000 Postcode Directory, made available by UKBORDERS.   
 
Each clinic was then mapped in ARCMap onto an administrative map of England, 
showing the country divided into Lower Super Output Areas (LSOA) from the 2001 
Census, which was also provided by UKBORDERS.  LSOAs are a geography 
created for the 2001 Census.  They have a minimum population of 1,000 people, a 
mean population of 1,500 and are generally made up of 4 to 6 census Output 
Areas, the smallest census geography unit
24.  We chose to work with LSOAs 
rather than Output Areas for two reasons.  Firstly as there are fewer LSOAs than 
Output Areas, the computing power required is reduced and secondly, due to 
disclosure requirements, data are readily available for LSOAs from Neighbourhood 
Statistics (provided by the Office for National Statistics) but not for Output Areas.  
Using data from the 2001 Census available from Neighbourhood Statistics, we 
obtained the population aged 16-44 years for each LSOA.   
 
Both the Thiessen polygons and the 15 mile boundaries around each clinic were 
drawn using ArcMap.  These figures were “clipped” to the LSOA map.  “Clipping” 
these figures ensures that the polygons and boundaries correctly trace the coastline of the UK and that they maintain the same projected coordinate system 
as the other data layers.  The total population aged 16-44 for each polygon was 
obtained by selecting within ARCMap the LSOAs which had their population 
centres within that polygon.  The population figures for the selected LSOAs were 
then summed to give a total population for each polygon.  When the population 
was to be restricted to the 15 mile boundary, LSOAs were only selected if their 
population centre fell within that distance.   
 
The population has been allocated to clinics on the assumption that people travel 
to the clinic closest to their address on the date of the 2001 census.  In practice, 
this is unlikely to be true for all attendees.  The most common reason for this is 
that clinics tend to have limited opening hours, restricted to the times when many 
people are at work.  A clinic in the town where an individual works may be more 
convenient than one near his or her home.  In large urban areas where many 
people work but fewer people live, we may thus under-estimate the population at 
risk and hence over-estimate the rate.  Similarly, in suburban areas, we may over-
estimate the population at risk and under-estimate the rate.   
 
There are several different approaches to creating a drive-time model.  The 
simplest is to use some of the readily available internet trip planning software such 
as www.multimap.com or Google Maps.  They have excellent data on the road 
network and provide good travel time estimates for single trips.  However, these 
are less useful when the travel time must be computed from a large number of 
starting points as each one has to be manually inputted.    
A vector-based model extends the theory used by this approach to a more general 
model. The model estimates the time that it will take to travel a particular road 
segment between nodes, or intersections of roads
25.  Figure 4 below illustrates 
how the vector model operates.  Imagine that the blue square is the postcode 
centroid in a particular region, the boundaries of which are represented by the blue 
lines.  The model then calculates the time taken to travel from the blue point to the 
road (the first red point), the time between each of the road intersections (the other 
red points) and the time between the road and the clinic (the green point).  Added 
together, these times give the total travel time.   
 
Figure 4.  Path-finding example in the vector model  
 
 However, this is just one possible path.  Another route, following the orange lines, 
could involve turning left onto Fulton Street, whilst still another involves a left onto 
Dey Street.  The vector model evaluates all possible paths between all the start 
points and end points which you specify and finds the shortest travel times.  For 
example, in the Northwest, the model would work out all the possible paths 
between approximately 4,500 LSOA centroids and the 25 GUM clinics and select 
the shortest.  The results would be returned in a 4,500 x 25 matrix of travel times.   
 
Such an approach is computationally intensive.  Moreover, because the 
calculations are done from centroids, there can be distortions.  For example, the 
blue point was the centroid for this particular area and from this point it might be 
quickest to travel to clinic A.  But for someone living on Wall Street (at the purple 
point in Figure 4, for example), clinic B is probably closer.  This will not be 
reflected in the calculations since all calculations will be done from the centroid.  
For these reasons, the vector model is usually more suited to calculations where 
we have a fixed set of start points, such as patient addresses, rather than being 
interested in travel times over a region more generally.   
 
So we have opted instead for a surface model.  The surface model is a raster-
based approach which involves creating a more generalised surface of drive times 
to each clinic by representing these as a continuous cost-surface
26.   First, we 
obtained a representation of the UK road network from the Ordinance Survey 
Digimap Collection (1:50,000 scale).  This includes 4 classifications of road types: 
motorway, A-road, B-road and minor road.  Each road type was then assigned a background speed.  This required us to make some assumptions about how 
quickly traffic moves along each road type.  A car’s speed, and hence the time 
taken to complete a journey, varies by time of day, by region and even by driver.       
 
The speeds we assigned to the roads in our model, shown in the table below, 
were based on the average road speeds reported by the Department of 
Transport
27 and upon empirical work to verify travel times to health services done 
by Haynes et al
28.  Roads in urban LSOAs were slowed to a speeds half of those 
in rural LSOAs to take into account the time-cost of traffic congestion in urban 
areas.  The designation of an LSOA as urban or rural was based on classifications 
made by the Rural and Urban Area Classification Project, a joint project sponsored 
by the Countryside Agency, the Department for the Environment, Food and Rural 
Affairs, the Office for National Statistics, the Office of the Deputy Prime Minister 
and the Welsh Assembly Government
29.  In areas where there are no roads, it was 
assumed that individuals could cross the land to the nearest road at a background 
walking speed. 
   
Table 1. Travel speeds 
Road type  Rural Speed (miles per hour)   Urban Speed (miles per hour) 
Motorway 65  33 
A-road 45  23 
B-road 30  15 
Minor road  20  10 
Walking 4  4  
It is important to note that our calculation of travel time will actually be a measure 
of estimated drive-times.  It will not include other activities which effect the overall 
travel time, such as the time spent trying to park at the clinic.  Nor does it 
represent the time taken to get to a clinic by individuals who do not have access to 
a car and who therefore rely on public transport.  Therefore these calculations will 
only represent an approximation of the true time taken for an individual to get to 
the clinic. 
 
Both the road network and the land area maps were then rasterised, turning the 
UK map into a grid of 100 metre squares in ARCMap.  The travel time to cross 
each square is calculated based on the background speeds assigned to each road 
type, creating a travel-time raster.  The Cost Distance function in the Spatial 
Analyst toolpack then uses this raster to calculate a value for each square which 
represents the least cost in terms of travel time between that square and nearest 
endpoint (clinics).  The travel times were used to trim the area around the clinics 
so that persons living more than 30 minutes away are not included in the exposed 
to risk.   
 
The road network will include 100 metre squares in which, for example, a 
motorway bridges a minor road.  The model does not realise that the motorway 
cannot be joined at this point and will calculate the travel time assuming that the 
individual joins the motorway.   The tendency of the model to ignore how the 
features of the road network actually interact is a small weakness in regional calculations such as ours which is interested in travel times over the whole of the 
Northwest and Southwest areas.  However if this method were to be applied to 
local area calculations, such as transit through Southampton, the problem could 
be substantial.   
 
3.3 SPATIAL CLUSTERING 
 
Once we have derived appropriately calculated rates of Chlamydia infection, we 
might be interested to know whether these rates conform to any patterns.  Do high 
rates cluster together?  Does the rate at one clinic seem to depend on the rates at 
other, surrounding clinics?  Spatial autocorrelation is a measure of the extent to 
which data exhibit this sort of clustering.  When high values are generally located 
near to other high values or low values near to other low values, the data are said 
to show positive spatial autocorrelation.  When it is distributed so that high values 
are generally next to low values, the data show negative spatial autocorrelation
30.   
 
In addition to providing us with information about the patterns of Chlamydia 
distribution, identifying any spatial autocorrelation is vital because most statistics, 
particularly in regression analyses, are based on the assumption that values are 
independent of one another.  The presence of spatial autocorrelation violates this 
assumption and so spatial dependence must be specifically controlled for in 
statistical calculations
31.    
 Spatial autocorrelation can be measured in a number of ways but the classic 
measure is Moran’s I.  It compares the value at one location with the value at all 
the other locations.  When I approaches 1, there is evidence of strong positive 
spatial autocorrelation, whilst an I approaching -1 shows evidence of strong 
negative spatial autocorrelation.  We can also obtain a Z-test statistic which tests 
the null hypothesis that the observed values are the result of a random process 
(no spatial autocorrelation) against the alternative hypothesis that there is spatial 
correlation.  These calculations have been done using GeoDa, a program created 
specifically for the analysis of spatial data.   
 4. RESULTS 
 
4.1 NUMBER OF CASES 
The numbers of cases reported at each clinic are presented in Tables 2 and 3 
below.  The highest numbers of cases in the Northwest were diagnosed in 
Liverpool and Manchester, which is unsurprising as these are the two largest cities 
in the region.  In the Southwest, the highest numbers of cases are diagnosed in 
Bristol and Bournemouth.  
 
Table 2. Chlamydia cases diagnosed at Northwest clinics  
Clinic  Chlamydia cases 
Ormskirk 92 
Workington Community Hospital   99 
Halton General Hospital   109 
Royal Albert Edward Infirmary, Wigan  116 
Burnley General Hospital   125 
St Helens and Knowsley Hospital  130 
Hope Hospital   138 
Cumberland Infirmary  144 
Chorley and South Ribble District General Hospital  144 
Warrington and District General Hospital  164 
Trafford General Hospital   191 
Macclesfield District General Hospital   201 
Leighton Hospital   208 Clinic  Chlamydia cases 
Fairfield General Hospital   235 
Ashton Community Care Centre  235 
Southport District General Hospital   279 
Royal Oldham Hospital   312 
Tameside and Glossop Centre for Sexual Health  328 
Royal Blackburn Hospital   364 
Royal Preston Hospital   393 
Stepping Hill Hospital  408 
Countess of Chester Hospital  415 
North Manchester Hospital   420 
Victoria Hospital, Blackpool  425 
Arrow Park Hospital   471 
Baillie Street Health Centre, Rochdale  528 
Royal Bolton Hospital   581 
Withington Hospital   706 
Manchester Royal Infirmary  758 
Royal Liverpool Hospital   1130 
 
 
 
 
 
 
  
Table 3. Chlamydia cases diagnosed at Southwest clinics  
Clinic  Chlamydia cases 
Newquay and District Hospital  35 
West Cornwall Hospital, Penzance  47 
Chippenham Community Hospital   50 
Weston General Hospital   59 
Yeovil District Hospital   99 
Royal Devon and Exeter Hospital  109 
Torbay Hospital   136 
North Devon District General Hospital   192 
Salisbury District Hospital   194 
Cheltenham General Hospital   197 
Weymouth and District Hospital  214 
Royal Cornwall Hospital, Treliske  225 
Taunton and Somerset Hospital  239 
Royal United Hospital, Bath  279 
The Great Western Hospital, Swindon  406 
Gloucester Royal Hospital   520 
Derriford Hospital Level 5, Plymouth  531 
Royal Bournemouth Hospital   700 
Bristol Royal Infirmary  881 
 4.2 THIESSEN POLYGONS 
Using the Thiessen polygon approach we can begin to see how the measures of 
disease incidence change once we control for the population exposed to risk.  The 
rates for each clinic, using the Thiessen polygon as the catchment area, are 
presented in Tables 4 and 5 below.  The 95% confidence intervals are based on 
the Poisson distribution and have been calculated in STATA.  Figures 4 and 5 
below show quartile maps of the rates in each Thiessen polygon for the Northwest 
and Southwest regions.   
 
The rates in the Northwest range from 1.12 per 1,000 at the Royal Albert Edward 
Infirmary in Wigan up to 8.56 per 1,000 at the Baillie Street Health Centre in 
Rochdale.  Although Liverpool had by far the most cases diagnosed, it only had 
the sixth highest rate.   And similarly though Southport was towards the middle of 
the table in terms of number of cases diagnosed, it has the fourth highest rate.   
 
In the Southwest, the rates range from  0.67 per 1,000 at Newquay and District 
Hospital up to 5.12 per 1,000 at Weymouth and District Hospital.  As in the 
Northwest, the position of many clinics in the table changed substantially when we 
controlled for the population exposed to risk.  Weymouth, for example, was in the 
middle of the table in terms of cases diagnosed but has the highest Chlamydia 
rate.   
 
The rates in the Southwest are much lower than were observed for the Northwest 
region.  The average Chlamydia rate for the whole Southwest using this method is 2.67 per 1000 population aged 16-44.  For the Northwest, the rate is 3.90 per 1000 
population aged 16-44.  The Health Protection Agency (HPA) estimates for these 
regions similarly show the Southwest rates as lower than those in the Northwest, 
with a rate of 1.45 per 1000 for the Northwest compared with 1.03 per 1000 for the 
Southwest
32.  These rates are calculated using a different exposed to risk, i.e. per 
1000 resident population rather than per 1000 population aged 16-44.  When we 
recalculated our average rates using the same population exposed to risk as the 
HPA, we were able to replicate their rates.  
 
The HPA estimated rate for all of England was 1.38 per 1000.
33  Although the 
Southwest region has much lower rates on average than the rest of the country 
and the Northwest has somewhat higher rates, the tables below show that this 
varies considerably by clinic.   
 
Table 4. Chlamydia rate for Northwest clinics  - Thiessen polygon catchment areas 
Clinic  Chlamydia rate per 1,000 
population 
95% Confidence Interval 
Royal Albert Edward Infirmary, Wigan  1.12  (0.92, 1.35) 
St Helens and Knowsley Hospital  1.22  (1.02, 1.45) 
Burnley General Hospital  1.53  (1.28, 1.83) 
Halton General Hospital  1.62  (1.33, 1.95) 
Ormskirk 1.71  (1.38,  2.10) 
Workington Community Hospital  1.98  (1.61, 2.41) 
Warrington and District General Hospital  2.05  (1.75, 2.39) Clinic  Chlamydia rate per 1,000 
population 
95% Confidence Interval 
Hope Hospital  2.45  (2.05, 2.89) 
Leighton Hospital  2.46  (2.14, 2.82) 
Cumberland Infirmary  2.47  (2.08, 2.90) 
Tameside & Glossop Sexual Health Centre  2.75  (2.46, 3.07) 
Chorley and South Ribble District General 
Hospital 
2.96 (2.46,  3.07) 
Stepping Hill Hospital  3.16  (2.83, 3.52) 
Fairfield General Hospital  3.28  (2.88, 3.73) 
Trafford General Hospital  3.36  (2.90, 3.87) 
Macclesfield District General Hospital  3.73  (3.23, 4.28) 
Royal Blackburn Hospital  3.79  (3.41, 4.20) 
Royal Bolton Hospital  3.86  (3.55, 4.19) 
Royal Oldham Hospital  3.96  (3.53, 4.43) 
Ashton Community Care Centre  3.97  (3.48, 4.51) 
Victoria Hospital, Blackpool  4.16  (3.77, 4.57) 
Royal Preston Hospital  4.20  (3.80, 4.64) 
Arrow Park Hospital  5.22  (4.76, 5.72) 
North Manchester Hospital  5.28  (4.79, 5.81) 
Royal Liverpool Hospital  5.54  (5.27, 5.81) 
Countess of Chester Hospital  5.99  (5.47, 6.94) 
Southport District General Hospital  6.17  (5.47, 6.94) 
Manchester Royal Infirmary  6.23  (5.80, 6.69) 
Withington Hospital  7.35  (6.82, 7.92) Clinic  Chlamydia rate per 1,000 
population 
95% Confidence Interval 
Baillie Street Health Centre, Rochdale  8.56  (7.85, 9.32) 
 
Table 5. Chlamydia rate for Southwest clinics - Thiessen polygon catchment areas 
Clinic  Chlamydia rate per 1,000 
population 
95% Confidence Interval 
Newquay and District Hospital  0.67  (0.47, 0.93) 
Chippenham Community Hospital  0.73  (0.54, 0.96) 
Weston General Hospital  0.84  (0.64, 1.08) 
Royal Devon and Exeter Hospital  0.95  (0.78, 1.14) 
Yeovil District Hospital  1.27  (1.03, 1.54) 
Torbay Hospital  1.56  (1.31, 1.84) 
West Cornwall Hospital, Penzance 1.72  (1.27, 2.29) 
Royal United Hospital, Bath  2.33  (2.06, 2.62) 
Cheltenham General Hospital  2.40  (2.07, 2.76) 
The Great Western Hospital, 
Swindon 
2.60 (2.35,  2.86) 
Taunton and Somerset Hospital  2.86  (2.51, 3.25) 
Bristol Royal Infirmary  2.97  (2.77, 3.17) 
Derriford Hospital Level 5, 
Plymouth 
3.31 (3.03,  3.60) 
North Devon District General 
Hospital 
3.52 (3.04,  4.06) 
Royal Bournemouth Hospital  3.67  (3.40, 3.95) Salisbury District Hospital  3.69  (3.19, 4.24) 
Royal Cornwall Hospital, Treliske  3.98  (3.48, 4.54) 
Gloucester Royal Hospital  4.35  (3.99, 4.74) 
Weymouth and District Hospital  5.12  (4.45, 5.85) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 4. Map of rates in the Northwest  
 
 
 Figure 5. Map of rates in the Southwest 
 4.3 15 MILE BOUNDARIES 
When we change the catchment area to exclude those individuals who live more 
than 15 miles from the clinic, as shown in Figures 4 and 5, we begin to see 
differences in the accessibility of clinics in the Northwest compared to the 
Southwest.   
 
Figure 6 shows that very little of the Northwest is not covered by one of the 15 mile 
boundaries (in purple).  The areas that are excluded, in the northern-most region 
of Cumbria, are relatively unpopulated and account for only 2% of the Northwest 
population aged 16-44 years.  These individuals were originally allocated to one of 
four clinics: Westmorland and Furness General Hospitals (which are not included 
above as they have chosen not to report their figures as discussed in Section 2), 
Cumberland Infirmary and Workington General Hospital.  The rates for 
Cumberland Infirmary and Workington General Hospital can be adjusted to 
exclude those who live outside the 15 mile boundary but it can be seen that even 
for these two clinics, the change is very small (From 2.47 to 3.18 for Cumberland 
and from 1.98 to 2.14 for Workington).  Remoteness with respect to distance from 
a clinic does not seem to be an issue in this region.   
 
 
 
 
 
 Figure 6. Northwest clinics with 15 mile boundaries 
 
    
 
 In contrast, the map (Figure 7) of the Southwest shows far more polygons 
containing areas that were classed as more than 15 miles from a clinic.   Virtually 
every clinic includes at least a small area that was deemed to be remote on this 
measure.  However, these areas were relatively sparsely populated and overall 
only about 6% of the population aged 16-44 years was affected.   
 
Figure 7. Southwest clinics with 15 mile boundaries 
 
 
 
Because the virtually every clinic has been affected, we recalculated the rates for 
the Southwest excluding those individuals for whom the clinic was considered to be remote.  This reduces the population exposed to risk (i.e. the denominator) and 
correspondingly increases the rates.  But these changes are spread across the 
clinics such that the changes to the rates are relatively small.  The new rates 
shown in Table 6 differ little from those derived using the Thiessen polygon 
method and the differences are not statistically significant, as illustrated by the 
overlapping 95% confidence intervals in Figure 8 below.   
 
Table 6. Chlamydia rate for Southwest clinics - 15 mile boundaries 
Clinic  Chlamydia rate per 1,000 
population 
95% Confidence Interval 
Chippenham Community Hospital  0.74  (0.55, 0.98)
Weston General Hospital  0.90  (0.68. 1.15)
Newquay and District Hospital  0.99  (0.69, 1.37)
Royal Devon and Exeter Hospital  1.04  (0.86, 1.26)
Yeovil District Hospital  1.52  (1.24, 1.86)
Torbay Hospital  1.60  (1.34, 1.89)
West Cornwall Hospital, Penzance  1.76  (1.29, 2.34)
Cheltenham General Hospital  2.47  (2.14, 2.84)
Royal United Hospital, Bath  2.57  (2.28, 2.89)
The Great Western Hospital, 
Swindon 2.60  (2.35,  2.86)
Bristol Royal Infirmary  2.99  (2.80, 3.20)
Taunton and Somerset Hospital  3.23  (2.83, 3.66)
Derriford Hospital Level 5, Plymouth  3.69  (3.38, 4.01)
Royal Bournemouth Hospital  3.77  (3.49, 4.05)Clinic  Chlamydia rate per 1,000 
population 
95% Confidence Interval 
Royal Cornwall Hospital, Treliske  4.07  (3.55, 4.64)
Salisbury District Hospital  4.10  (3.54, 4.71)
North Devon District General 
Hospital  4.65 (4.02,  5.36)
Gloucester Royal Hospital  4.77  (4.37, 5.19)
Weymouth and District Hospital  5.22  (4.54, 5.97)
 
Figure 8. Comparison of rates in the Southwest derived using the Thiessen and 15 
mile methods (bars denote 95 percent confidence intervals) 
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4.4 DRIVING TIMES 
Remoteness with respect to the driving time is not much of an issue in the 
Northwest.  Table 7 below shows the percentage of the population that lives within 
a given drive-time of a GUM clinic.  Only 2% of the population lives more than 30 
minutes from a clinic and only 6% more than 20 minutes.   
 
Table 7. Travel time to the nearest clinic in Northwest 
Time to nearest clinic  % of population living 
within this travel time to 
nearest clinic 
Cumulative % of 
population living within 
this time to nearest clinic 
0 – 5 minutes  20%  20% 
5 – 10 minutes  39%  59% 
10 – 15 minutes  25%  85% 
15 – 20 minutes  9%  94% 
20 – 25 minutes  3%  97% 
25 – 30 minutes   1%   98% 
30 – 35 minutes  1%  99% 
35 – 40 minutes  0%  99% 
40 – 60 minutes  1%  100% 
60 minutes plus  0%  100% 
 
Although some areas (shown in dark blue on Figure 9 below) are clearly less 
accessible they are mainly in the less populated, more rural areas which do not 
have easy access to the motorways and A-roads.  The same clinics are affected by this remoteness as when measured with the crow-fly distance approach, 
though the travel time model does manage to give further refinement.  For 
example, although the individuals in the vicinity of the Burnley clinic were all within 
15 miles, a number were found by the travel-time model to live more than 30 
minutes away.   
 
For the Northwest, it seems that we add very little by moving away from the 
Thiessen approach.  Most people are able to easily access their nearest clinic and 
so the added complexity of the distance and travel time models are not needed.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 9. Northwest clinics with 30 minute drive-time catchment areas 
 
 
 
The situation in the Southwest is very different.  The travel time analysis also 
shows a number of areas where clinic access is problematic. As shown in Table 8 below, 10% of the population live more than 30 minutes away from a clinic and 
almost one in three live more than 20 minutes away.  Much like when we drew the 
15 mile boundaries, Figure 10 shows that virtually every clinic’s catchment area 
contains an area which is considered remote, denoted by a dark blue patch, from 
which the trip will take more than 30 minutes.   
 
Table 8. Travel time to the nearest clinic in Southwest 
Time to nearest clinic  % of population living 
within this travel time to 
nearest clinic 
Cumulative % of 
population living within 
this time to nearest clinic 
0 – 5 minutes  16%  16% 
5 – 10 minutes  23%  39% 
10 – 15 minutes  17%  56% 
15 – 20 minutes  14%  70% 
20 – 25 minutes  11%  81% 
25 – 30 minutes   9%  90% 
30 – 35 minutes  4%  94% 
35 – 40 minutes  3%  97% 
40 – 60 minutes  3%  100% 
60 minutes plus  0%  100% 
 
 
 
 
 Figure 10. Southwest clinics with 30 minute drive-time catchment areas 
 
 
 
However, the impact on the rates is once again very limited (Table 9).  For most 
clinics, they increase compared to both the rates calculated using the Thiessen 
and the crow-fly distance methods.  This reflects the further reduction in the 
denominator as we exclude those individuals who live more than 30 minutes away. 
But the increases are modest and again, as shown in Figure 11 below, not 
statistically significant as the 95% confidence intervals overlap.   Table 9. Chlamydia rate for Southwest clinics – 30 minute drive time 
Clinic  Chlamydia rate per 1,000 
population 
95% Confidence Interval 
Chippenham Community Hospital  0.82 (0.61, 1.08)
Weston General Hospital  0.89 (0.68, 1.15)
Newquay and District Hospital  0.90 (0.63, 1.25)
Royal Devon and Exeter Hospital  1.08 (0.88, 1.30)
Yeovil District Hospital  1.66 (1.34, 2.01)
Torbay Hospital  1.71 (1.43, 2.02)
West Cornwall Hospital, Penzance  1.76 (1.29, 2.34)
Cheltenham General Hospital  2.56 (2.21, 2.94)
Royal United Hospital, Bath  2.69 (2.38, 3.02)
Bristol Royal Infirmary  3.00 (2.80, 3.20)
The Great Western Hospital, 
Swindon 3.09 (2.79,  3.40)
Taunton and Somerset Hospital  3.33 (2.92, 3.78)
Royal Bournemouth Hospital  4.01 (3.71, 4.31)
Derriford Hospital Level 5, 
Plymouth  4.09 (3.75, 4.45)
Royal Cornwall Hospital, Treliske  4.30 (3.75, 4.90)
Salisbury District Hospital  4.44 (3.84, 5.12)
North Devon District General 
Hospital 4.77 (4.12,  5.49)
Gloucester Royal Hospital  4.95 (4.54, 5.40)
Weymouth and District Hospital  5.67 (4.94, 6.49)
  
Figure 11. Comparison of rates in the Southwest on all three methods 
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However, if we calculate the rates using a drive time of less than 20 minutes, 
rather than 30 minutes, the change to the rates is substantial as shown in Figure 
12.  This is because 30% of the population in the Southwest must travel for more 
than 20 minutes to access their nearest GUM clinic.  Excluding these individuals from the calculations means very large reductions to the exposed to risk.  Some 
clinics are more affected than others. The population exposed to risk in Swindon 
reduces by only 8% in comparison with the population used in the Thiessen 
polygon approach.  In contrast the population exposed to risk in Newquay reduces 
by 69%.  Although 30 minutes has been used in a number of previous studies, 
clearly areas of the Southwest are very sensitive to the threshold chosen.  There is 
little empirical evidence about the amount of time individuals are willing or able to 
spend travelling in order to access sexual health services.  Further research in this 
area is needed in order to assess whether there is a significant problem with 
accessibility in the Southwest.   
 
Table 10 shows the rates using the 20 minute drive time model.  Comparing this to 
Table 9, which shows the results of the 30 minute model, shows that there is little 
change in the order in which the clinics occur.  Those with the lowest rates in the 
30 minute model are also those with the lowest rates in the 20 minute model.  
Although the rates may be higher using a 20 minute threshold, and although some 
clinics may be more affected than others, overall the areas that we have identified 
as areas with high rates remain areas of high rates regardless of the method 
chosen.   
 
 
 
 Figure 12.  Comparison of rates in the Southwest, including 20 minute drive-time 
threshold 
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 Table 10. Chlamydia rate for Southwest clinics – 20 minute drive time 
 
Clinic  Chlamydia rate per 
1,000 population 
Chippenham Community Hospital  1.17
Weston General Hospital  1.22
Royal Devon and Exeter Hospital  1.48
Torbay Hospital  1.98
Newquay and District Hospital  2.16
West Cornwall Hospital, Penzance  2.26
Yeovil District Hospital  2.51
The Great Western Hospital, Swindon  2.82
Cheltenham General Hospital  3.05
Bristol Royal Infirmary  3.21
Royal United Hospital, Bath  4.28
Taunton and Somerset Hospital  4.54
Royal Bournemouth Hospital  4.83
Derriford Hospital Level 5, Plymouth  4.96
Salisbury District Hospital  6.59
Weymouth and District Hospital  6.62
Royal Cornwall Hospital, Treliske  6.65
Gloucester Royal Hospital  7.36
North Devon District General Hospital  7.76
 
 4.5 CONCLUSION 
The method used to calculate the denominator made very little difference to the 
rates that we obtained.  The impact of trying to account for crow-fly and travel time 
measures of distance was greater in the Southwest than in the Northwest and it 
resulted in marginally higher rates.  However, this change to the rates was not 
statistically significant.  Using the simple Thiessen polygon approach seems to be 
as good in both regions as using more complex models.   
 
Having said that, further research is required in order to determine whether the 
thresholds that we have chosen to use here are the most appropriate to measure 
accessibility of clinics.  Results in the Southwest, for example, are particularly 
sensitive to whether a 20 or 30 minute drive-time is used and the more complex 
drive-time model may be justified should further studies show that a 20 minute 
threshold is more representatives of the journeys that individuals actually make.   
 
But if the primary interest is not the point estimate of the rates but their magnitude, 
i.e. which areas have relatively higher or lower rates, then the method chosen 
seems to make little difference.   
 
4.6 SPATIAL CLUSTERING 
 
In the quartile maps of the rates using the Thiessen polygon approach (Figures 4 
and 5), there did not seem to be any initial evidence of clustering.  Moran’s I for 
the Northwest was 0.051 (p value = 0.20) showing no evidence of spatial autocorrelation.  In the Southwest, Moran’s I was -0.26 (p value=0.12) which also 
showed no evidence of spatial autocorrelation.  We can therefore conclude that 
the rates are spatially independent of one another.   
 5. DISCUSSION 
 
This study has shown that it is possible to calculate rates of Chlamydia infection 
for individual GUM clinics in the Northwest and Southwest region of England.  
Were the data available, it would be possible to extend the methods used here to 
calculate rates for all UK clinics based on their KC60 returns.  Rates were found to 
be higher in the Northwest than in the Southwest.  The average rate for the whole 
of the Northwest region was found to be higher than the English national average 
whilst the average for the Southwest region was substantially lower than the 
national average.  However considerable variation existed between clinics within 
regions.  Further research is needed in order to establish why such variations 
occur.   
 
Our calculations were based on the application of three different techniques of 
varying complexity to derive the population exposed to risk.  It was found that the 
technique selected had little impact on the results and therefore we recommend 
that future studies use the simplest method of calculation, i.e. the Thiessen 
polygon approach.  This is especially true if we are mainly interested in identifying 
areas which are Chlamydia “hot spots”.  Although the point estimates of the rates 
changed depending on the method used, the clinics with higher rates calculated 
on one method tended to be also have high rates when calculated using the other 
methods.   
 However, the drive-time model highlighted issues surrounding the accessibility of 
GUM clinics in the Southwest.  Point estimates of the rates in the Southwest 
region were very sensitive to the drive-time threshold used.  Approximately 10% of 
the population lives more than 30 minutes from their nearest clinic and the 
exclusion of these individuals from the exposed to risk did not affect the rates in a 
statistically significant way.  But if a 20 minute threshold is used, the changes to 
the rates were much more substantial, as 30% of the population live more than 20 
minutes from their nearest clinic.  We have used the 30 minute threshold in this 
paper, as this threshold has been used in previous research.  However, its 
selection seems to have little basis in empirical evidence and it seems that further 
research is required to confirm how individuals access sexual health services.   
 
Where there are issues of accessibility, such as in the Southwest, it is possible 
that people who do not live near to a clinic would be more likely to call upon other 
local services, such their GP, for treatment.  This problem has been acknowledged 
by the South West Health Protection Authority which writes, “It is still apparent that 
a large proportion of diagnoses are being made by GPs or in other clinical 
settings. This has implications for commissioning services as most data released 
are based on KC60 returns and therefore may vastly underestimate the burden of 
disease in the wider community.”
34 
 
However, the currently available data leave administrators little choice other than 
to base service allocations and commissions on KC60 data.  The Health 
Protection Authority and the Department of Health are looking at ways of ensuring that data collected about sexually transmitted diseases are more accurate and 
more readily available.  The Common Data Set for Sexual Health (CDSSH) is 
currently in its second pilot stage
35.  Once released, it will provide information on 
diagnoses from a variety of healthcare settings including both GP surgeries and 
GUM clinics.  It will record patient demographic information, including postcode of 
residence, and a full sexual history
36.   
 
But as yet, there is no final release date for the CDSSH and it remains unclear 
who will have access to the data.  In the interim, deriving rates calculated using a 
sound methodology represents the first step in getting more out of the existing 
data available from the KC60 returns.  Although these data cannot provide 
information on service settings other than GUM clinics, it does represent the best 
data currently available and allows us to explore differences in rates of sexually 
transmitted disease between groups, locations or over time.  Moreover for areas 
such as the Northwest, where accessibility is generally good, the additional call on 
GP and other services is likely to be limited, making GUM clinic rates a more valid 
estimate of the true population rates.   
 
Sexual health was highlighted as one of the key target areas in “Choosing Health” 
White paper in 2004.  Making progress on tackling sexually transmitted diseases 
will therefore require that we analyse existing data to help us to answer such 
fundamental questions as “Why are Chlamydia rates higher in some areas than in 
others?”.  We hope in a future paper to explore some possible explanations for 
this, exploring correlations between the rates derived here and data on sexual behaviour and patterns of diagnosis and referral for treatment.  Such analyses will 
assist us in targeting interventions so that they not only reach the locations and 
individuals who most need them, but also address the underlying reasons for the 
higher risk to these populations.   
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